AI may represent a new tool in the risk assessment and screening pathway of breast cancer. To realise its potential, the effect of AI-supported decisions on relevant clinical outcomes must be prospectively evaluated.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Guiding principles for the responsible development of artificial intelligence tools for healthcare
Communications Medicine Open Access 01 April 2023
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Lauby-Secretan, B. et al. New Engl. J. Med. 372, 2353–2358 (2015).
Esserman, J. J. et al. NPJ Breast Cancer 3, 34 (2017).
Pashayan, N. et al. Nat. Rev. Clin. Oncol. 17, 687–705 (2020).
Yala, A. et al. Nat. Med. https://doi.org/10.1038/s41591-021-01599-w (2021).
Houssami, N. et al. Breast 38, 150–153 (2018).
Trentham-Dietz, A. et al. Ann. Int. Med. 165, 700–712 (2016).
Tice, J. A. et al. J. Clin. Oncol. 33, 3137–3143 (2015).
Terry, M. B. et al. Lancet Oncol. 20, 504–517 (2019).
Pal, C. P. et al. J. Natl Cancer Inst. 112, 278–285 (2020).
Eriksson, M. et al. Radiology 297, 327–333 (2020).
Kerlikowske, K. et al. J. Natl Cancer Inst. 113, 909–916 (2021).
Aarts, A. et al. J. Med. Screen. 26, 147–153 (2019).
Acknowledgements
N.H. receives funding via the National Breast Cancer Foundation (NBCF) Chair in Breast Cancer Prevention grant (EC-21-001).
Author information
Authors and Affiliations
Contributions
N.H. and K.K. contributed equally to this article.
Corresponding author
Ethics declarations
Competing interests
N.H. is collaborating in evaluations of various AI algorithms for mammography screening. N.H. does not receive any funding or sponsorship from the AI industry, and is not involved in the development of AI systems.
Rights and permissions
About this article
Cite this article
Houssami, N., Kerlikowske, K. AI as a new paradigm for risk-based screening for breast cancer. Nat Med 28, 29–30 (2022). https://doi.org/10.1038/s41591-021-01649-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-021-01649-3
This article is cited by
-
Guiding principles for the responsible development of artificial intelligence tools for healthcare
Communications Medicine (2023)